Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 25 peer-reviewed journal articles Updated
Dermatology · Frontal Fibrosing Alopecia

Do Finasteride and Dutasteride Work for FFA? Risks Explained

At a Glance

Finasteride and dutasteride are off-label options that may slow or stabilize frontal fibrosing alopecia, but they cannot regrow hair lost to scarring. Dermatologists often combine them with anti-inflammatory treatment and review pregnancy precautions and side effects because evidence remains limited.

In this answer

3 sections

01

Setting Realistic Expectations: Stabilization, Not Regrowth

02

A Team Approach to Treatment

03

What to Know Before Taking These Medications

Both finasteride and dutasteride are medications known as 5-alpha reductase inhibitors. They are often considered as an off-label treatment option for Frontal Fibrosing Alopecia (FFA) to help slow or stop further hairline recession. While observational studies and small trials suggest they can help stabilize hair loss for many people, they do not regrow hair in areas where follicles have already been destroyed by scarring [1][2][3]. Because FFA is primarily an inflammatory scarring condition, the exact role of these medications—which reduce androgen and dihydrotestosterone (DHT) levels—is not fully established. Therefore, specialized dermatologists typically prescribe them alongside anti-inflammatory treatments rather than on their own [4][5]. The evidence for their use in FFA is limited and mostly observational, so the decision to take them requires carefully weighing their potential benefits against strict pregnancy precautions and possible side effects [6][7].

Setting Realistic Expectations: Stabilization, Not Regrowth

Frontal fibrosing alopecia causes permanent hair loss through scarring [2]. The practical goal of taking finasteride or dutasteride is disease stabilization—preventing the hairline and eyebrows from receding further [1].

  • Dutasteride: Observational studies and reviews estimate that oral dutasteride helps stabilize the disease in roughly 63% of patients [8][9]. While one retrospective study noted higher stabilization rates with higher weekly doses, this is observational data, not proof that a higher dose works better or is safe for everyone [9]. You should never increase your dose on your own.
  • Finasteride: Smaller studies show that daily finasteride can also help halt progression, especially when combined with other treatments [10][11].

Because these studies differ in their designs, durations, and combinations of treatments, the results cannot be directly compared to say one drug is definitively better than the other [10][9]. It takes time to see if the medication is working. Dermatologists typically evaluate your response over several months (often 3 to 12 months) by looking at symptoms (like itching or redness) alongside standardized photographs and trichoscopy (a magnified look at your scalp) [12][10][9]. Progression can sometimes continue despite treatment, and the long-term effects of stopping the medication remain uncertain [13][14].

A Team Approach to Treatment

Finasteride and dutasteride are rarely used as standalone treatments for FFA. Because active inflammation attacks the hair follicles, specialized practice often involves a multimodal approach [4]. This means these pills are frequently prescribed alongside treatments that calm inflammation, such as:

  • Topical or injected corticosteroids [4][5]
  • Calcineurin inhibitors (like topical pimecrolimus) [10]
  • Oral anti-inflammatory medications like hydroxychloroquine, which has its own monitoring requirements, including regular eye exams [10][4]

What to Know Before Taking These Medications

Because these drugs alter hormone pathways by blocking the conversion of testosterone to DHT, they carry specific risks [7]. Approvals for hair loss vary by country, and their use in FFA is generally off-label. Dosing is not universally standardized, so your doctor will tailor a plan to your specific situation [9][11].

Strict Pregnancy Precautions

These medications are highly teratogenic, meaning they can cause severe birth defects in male fetuses [7][15].

  • Women who are pregnant, trying to conceive, or who may become pregnant must avoid taking them and use strict, reliable contraception [7].
  • Because these drugs can remain in the body for long periods, anyone planning a pregnancy must discuss stopping the medication and contraception timelines well in advance with their prescriber [16].
  • Pregnant women should not handle crushed or broken finasteride tablets, or opened/leaking dutasteride capsules, as the active ingredients can be absorbed through the skin [17].

Potential Side Effects

While many patients tolerate these medications well [10][9], they can cause side effects that warrant close monitoring:

  • Sexual and Reproductive Effects: In men, they can reduce libido, cause erectile or ejaculatory dysfunction, and impact sperm count and fertility [18][19][20]. While fewer sexual side effects have been reported in women, the frequency and risk in women are not well established due to limited data [21]. Breast tenderness or enlargement can also rarely occur [22].
  • Mood Changes: There are reports of depressive symptoms and mood changes associated with these medications, though the exact causal link is still being studied [23][24]. You should inform your doctor if you have a personal or family history of depression [6].
  • Prostate Screening (PSA): For people with a prostate who undergo screening, it is critical to tell your doctor you are taking a 5-alpha reductase inhibitor. These drugs significantly lower PSA (prostate-specific antigen) levels, meaning future test results must be adjusted and interpreted correctly by your healthcare team [22][25].

When to Contact Your Clinician

Do not wait for your next scheduled appointment if you experience:

  • New or worsening depression, or significant mood changes. Seek urgent medical help if you experience suicidal thoughts.
  • Troublesome sexual or reproductive side effects, or new breast changes.
  • Pregnancy, or suspected pregnancy exposure.
  • Signs of active FFA progression, such as worsening redness, scaling, pain, itching, or rapid hairline recession.

Common questions in this guide

Do finasteride and dutasteride help stop frontal fibrosing alopecia from progressing?
They may slow or stabilize frontal fibrosing alopecia for some people, but the evidence is limited and mostly observational. Dutasteride has been associated with stabilization in roughly 63% of patients in observational studies, while smaller studies suggest finasteride may help, especially when combined with other treatments.
Can finasteride or dutasteride regrow hair lost from frontal fibrosing alopecia?
No. Frontal fibrosing alopecia destroys hair follicles through scarring, so finasteride and dutasteride cannot usually regrow hair where follicles have already been destroyed. Their practical goal is to prevent or slow additional hairline and eyebrow recession.
Is dutasteride more effective than finasteride for frontal fibrosing alopecia?
Current studies do not prove that one medicine is better than the other. The studies used different designs, treatment combinations, and follow-up periods, so their results cannot be directly compared. Your clinician should choose the medication and dose for your situation.
How will my dermatologist know whether treatment is working for FFA?
Your dermatologist may assess itching, redness, scaling, pain, and hairline changes over about 3 to 12 months using standardized photographs and trichoscopy, which is a magnified scalp examination. Hair loss can still progress despite treatment, so your plan may need adjustment.
What pregnancy precautions are needed with finasteride or dutasteride?
These medicines can cause severe birth defects in a male fetus. Anyone who is pregnant, trying to conceive, or could become pregnant should not take them and should discuss reliable contraception and stopping timelines with the prescriber. Pregnant people should not handle crushed or broken finasteride tablets or opened or leaking dutasteride capsules.
What side effects should I watch for while taking these medicines?
Reported effects, particularly in men, include lower sex drive, erectile or ejaculation problems, changes in sperm count or fertility, breast tenderness or enlargement, and mood changes such as depression. Tell your clinician about new or worsening mood symptoms, troublesome sexual or reproductive effects, or breast changes, and seek urgent help for suicidal thoughts.
Why should I tell my doctor about these medicines before a PSA test?
Finasteride and dutasteride can significantly lower prostate-specific antigen, or PSA, levels. Your healthcare team must know that you take one of these medicines so they can adjust and interpret the test correctly.

Related questions

Are There New Treatments for Treatment-Resistant LPP? Can FFA Eyebrow and Eyelash Loss Be Treated Safely? Can Lichen Planopilaris Affect Body Hair or Nails? Can Lichen Planopilaris Relapse After Stopping Treatment? Can Wigs, Adhesives, or Tight Styles Worsen LPP or FFA?
Show more
How Do I Find an LPP Dermatologist for Scarring Alopecia? How Long Does Lichen Planopilaris Last? LPP Remission How Long Does LPP Treatment Take to Work? Measuring Response How Long Must LPP or FFA Be Inactive for Hair Transplant? What Treatment Options Come Next for Lichen Planopilaris? What Are Lichen Planopilaris Steroid Injection Side Effects? What Causes LPP? Stress, Hormones, or Autoimmunity? What Is the Difference Between LPP, FFA, and GLPLS? What Monitoring Tests Are Needed for LPP Medicines? Are LPP/FFA Treatments Safe in Pregnancy or Breastfeeding? Why Use Horizontal and Vertical LPP Biopsy Sections?

Get notified when new evidence is published on Lichen planopilaris.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (25)
  1. 1

    Hair transplantation for the treatment of lichen planopilaris and frontal fibrosing alopecia: A report of two cases.

    Liu YS, Jee SH, Chan JL

    The Australasian journal of dermatology 2018; (59(2)):e118-e122 doi:10.1111/ajd.12682.

    PMID: 28736812
  2. 2

    Frontal fibrosing alopecia: efficacy of treatment modalities.

    Gamret AC, Potluri VS, Krishnamurthy K, Fertig RM

    International journal of women's health 2019; (11()):273-285 doi:10.2147/IJWH.S177308.

    PMID: 31118828
  3. 3

    5-alpha-reductase inhibitor treatment for frontal fibrosing alopecia: an evidence-based treatment update.

    Murad A, Bergfeld W

    Journal of the European Academy of Dermatology and Venereology : JEADV 2018; (32(8)):1385-1390 doi:10.1111/jdv.14930.

    PMID: 29524253
  4. 4

    Consensus Document on the Clinical Management of Frontal Fibrosing Alopecia: Recommendations From Spanish Working Group on Trichology and Onychology of the AEDV.

    Saceda-Corralo D, Combalia A, Fernandez-Crehuet P, et al.

    Actas dermo-sifiliograficas 2026; (117(1)):104486 doi:10.1016/j.ad.2025.104486.

    PMID: 41344613
  5. 5

    Frontal fibrosing alopecia: clinical and prognostic classification.

    Moreno-Arrones OM, Saceda-Corralo D, Fonda-Pascual P, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2017; (31(10)):1739-1745 doi:10.1111/jdv.14287.

    PMID: 28426907
  6. 6

    Post-finasteride syndrome.

    Pereira AFJR, Coelho TOA

    Anais brasileiros de dermatologia 2020; (95(3)):271-277 doi:10.1016/j.abd.2020.02.001.

    PMID: 32317131
  7. 7

    Adverse Effects and Safety of 5-alpha Reductase Inhibitors (Finasteride, Dutasteride): A Systematic Review.

    Hirshburg JM, Kelsey PA, Therrien CA, et al.

    The Journal of clinical and aesthetic dermatology 2016; (9(7)):56-62.

    PMID: 27672412
  8. 8

    Dutasteride in the treatment of frontal fibrosing alopecia: Systematic review and meta-analysis.

    Seo HM, Oh SU, Kim S, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2024; (38(8)):1514-1521 doi:10.1111/jdv.19802.

    PMID: 38357767
  9. 9

    Effectiveness of dutasteride in a large series of patients with frontal fibrosing alopecia in real clinical practice.

    Pindado-Ortega C, Saceda-Corralo D, Moreno-Arrones ÓM, et al.

    Journal of the American Academy of Dermatology 2021; (84(5)):1285-1294 doi:10.1016/j.jaad.2020.09.093.

    PMID: 33038469
  10. 10

    Clinical effectiveness of finasteride versus hydroxychloroquine in the treatment of frontal fibrosing alopecia: A randomized controlled trial.

    Saber M, Farokhshahi M, Fatemi Naeini F, et al.

    Journal of cosmetic dermatology 2024; (23(2)):576-584 doi:10.1111/jocd.15993.

    PMID: 37691183
  11. 11

    Efficacy of Isotretinoin and Acitretin in Treatment of Frontal Fibrosing Alopecia: Retrospective Analysis of 54 Cases.

    Rakowska A, Gradzińska A, Olszewska M, Rudnicka L

    Journal of drugs in dermatology : JDD 2017; (16(10)):988-992.

    PMID: 29036252
  12. 12

    Lichen planopilaris and frontal fibrosing alopecia: review and update of diagnostic and therapeutic features.

    Fechine COC, Valente NYS, Romiti R

    Anais brasileiros de dermatologia 2022; (97(3)):348-357 doi:10.1016/j.abd.2021.08.008.

    PMID: 35379508
  13. 13

    Frontal Fibrosing Alopecia in Women: The Mayo Clinic Experience With 148 Patients, 1992-2016.

    Imhof RL, Chaudhry HM, Larkin SC, et al.

    Mayo Clinic proceedings 2018; (93(11)):1581-1588 doi:10.1016/j.mayocp.2018.05.036.

    PMID: 30392542
  14. 14

    Frontal fibrosing alopecia: a case series of 65 patients seen in a single Italian centre.

    Starace M, Brandi N, Alessandrini A, et al.

    Journal of the European Academy of Dermatology and Venereology : JEADV 2019; (33(2)):433-438 doi:10.1111/jdv.15372.

    PMID: 30472804
  15. 15

    Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date.

    Iamsumang W, Leerunyakul K, Suchonwanit P

    Drug design, development and therapy 2020; (14()):951-959 doi:10.2147/DDDT.S240615.

    PMID: 32184564
  16. 16

    Efficacy and safety of dutasteride in the treatment of alopecia: a comprehensive review.

    Gupta AK, Talukder M

    Expert opinion on pharmacotherapy 2025; (26(4)):367-379 doi:10.1080/14656566.2025.2461169.

    PMID: 39880789
  17. 17

    The pregnant urologist.

    Hall SJ, Williams ST

    BJU international 2017; (120(5)):731-734 doi:10.1111/bju.13927.

    PMID: 28581066
  18. 18

    Impact of 5-alpha reductase inhibitors on male reproductive health: A review of finasteride and dutasteride.

    Quintero T, Gratz B, Pepperney L, et al.

    Reproductive toxicology (Elmsford, N.Y.) 2026; (143()):109257 doi:10.1016/j.reprotox.2026.109257.

    PMID: 42069234
  19. 19

    Sexual dysfunction associated with 5α-reductase inhibitors in the treatment of androgenetic alopecia: a systematic review.

    Złotowska A, Jastrząb-Miśkiewicz B, Krajewski PK

    Frontiers in medicine 2026; (13()):1787706 doi:10.3389/fmed.2026.1787706.

    PMID: 42396141
  20. 20

    Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis.

    Corona G, Tirabassi G, Santi D, et al.

    Andrology 2017; (5(4)):671-678 doi:10.1111/andr.12353.

    PMID: 28453908
  21. 21

    Side Effects Related to 5 α-Reductase Inhibitor Treatment of Hair Loss in Women: A Review.

    Seale LR, Eglini AN, McMichael AJ

    Journal of drugs in dermatology : JDD 2016; (15(4)):414-9.

    PMID: 27050696
  22. 22

    How to Deal with the Issues of Fertility, Malignancies, and the Postfinasteride Syndrome while Prescribing Finasteride for Male Pattern Hair Loss.

    Trüeb RM, Luu NC, Gavazzoni Dias MFR, Dutra Rezende H

    Skin appendage disorders 2022; (8(3)):245-248 doi:10.1159/000520493.

    PMID: 35707289
  23. 23

    Finasteride Use: Evaluation of Depression and Suicide Risk.

    Gupta AK, Bamimore MA, Williams G, Talukder M

    Journal of cosmetic dermatology 2025; (24(3)):e70102 doi:10.1111/jocd.70102.

    PMID: 40082195
  24. 24

    Risk of Depression Associated With Finasteride Treatment.

    Pompili M, Magistri C, Maddalena S, et al.

    Journal of clinical psychopharmacology 2021; (41(3)):304-309 doi:10.1097/JCP.0000000000001379.

    PMID: 33814544
  25. 25

    Change in Prostate Specific Antigen Concentration in Men with Prostate Specific Antigen Less than 2.5 ng/ml Taking Low Dose Finasteride or Dutasteride for Male Androgenetic Alopecia.

    Kang HW, Chae MH, Park SH, et al.

    The Journal of urology 2017; (198(6)):1340-1345 doi:10.1016/j.juro.2017.07.075.

    PMID: 28743526

This page discusses off-label finasteride and dutasteride for frontal fibrosing alopecia for informational purposes only and does not constitute medical advice. Discuss treatment, pregnancy precautions, and side effects with your dermatologist.